Windsor James Brian insider trades
Windsor James Brian has filed 6 Form 4s with the SEC that we hold, all for Rein Therapeutics, Inc. (RNTX), as See Remarks, Director. Across all of them we count 5 purchases worth $36.7K and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($25.0K) and 0 sales ($0). The largest single trade was a purchase of 25,000 shares of Rein Therapeutics, Inc. worth $25.0K, dated 2026-04-30. The first filing on our record is dated 2023-11-21 and the latest 2026-05-13.
Rein Therapeutics, Inc. (RNTX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-11-20 | P, purchase reported on Form 4 | 5,076 | $10.0K | 2023-11-21 |
| 2023-12-15 | P, purchase reported on Form 4 | 225 | $758 | 2023-12-18 |
| 2024-12-05 | P, purchase reported on Form 4 | 239 | $535 | 2024-12-09 |
| 2024-12-05 | P, purchase reported on Form 4 | 161 | $362 | 2024-12-09 |
| 2026-04-30 | P, purchase reported on Form 4 | 25,000 | $25.0K | 2026-05-13 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1790933) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms